Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy

Stephan Waldmüller, Sadayappan Sakthivel, Abdul Vahab Saadi, Carmen Selignow, Pareppally Gopal Rakesh, Maria Golubenko, Pulavelli Kurian Joseph, Ramachandran Padmakumar, Pascale Richard, Ketty Schwartz, Jagan Mohan Tharakan, Chellam Rajamanickam, Hans Peter Vosberg

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Mutations causing familial hypertrophic cardiomyopathy (HCM) have been described in at least 11 genes encoding cardiac sarcomeric proteins. In this study, three previously unknown deletions have been identified in the human cardiac genes coding for β-myosin heavy chain (MYH7 on chromosome 14) and myosin-binding protein-C (MYBPC3 on chromosome 11). In family MM, a 3-bp deletion in MYH7 was detected to be associated with loss of glutamic acid in position 927 (ΔE927) of the myosin rod. In two other families (HH and NP, related by a common founder) a 2-bp loss in codon 453 (exon 16) of MYBPC3 was identified as the presumable cause of a translation reading frame shift. Taken together 15 living mutation carriers were investigated. Six deceased family members (with five cases of premature sudden cardiac death (SCD) in families MM and NP) were either obligate or suspected mutation carriers. In addition to these mutations a 25-bp deletion in intron 32 of MYBPC3 was identified in family MM (five carriers) and in a fourth family (MiR, one HCM patient, three deletion carriers). In agreement with the loss of the regular splicing branch point in the altered intron 32, a splicing deficiency was observed in an exon trapping experiment using MYBPC3 exon 33 as a test substrate. Varying disease profiles assessed using standard clinical, ECG and echocardiographic procedures in conjunction with mutation analysis led to the following conclusions: (1) In family MM the ΔE927 deletion in MYH7 was assumed to be associated with complete penetrance. Two cases of reported SCD might have been related to this mutation. (2) The two families, HH and NP, distantly related by a common founder, and both suffering from a 2-bp deletion in exon 16 of MYBPC3 differed in their average phenotypes. In family NP, four cases of cardiac death were documented, whereas no cardiac-related death was reported from family HH. These results support the notion that mutations in HCM genes may directly determine disease penetrance and severity; however, a contribution of additional, unidentified factors (genes) to the HCM phenotype can - at least in some cases - not be excluded. (3) The deletion in intron 32 of MYBPC3 was seen in two families, but in both its relation to disease was not unequivocal. In addition, this deletion was observed in 16 of 229 unrelated healthy individuals of the population of the South Indian states of Kerala and Tamil Nadu. It was not seen in 270 Caucasians from Russia and western Europe. Hence, it is considered to represent a regional genetic polymorphism restricted to southern India. The association of the deletion with altered splicing in transfected cells suggests that this deletion may create a "modifying gene", which is per se not or only rarely causing HCM, but which may enhance the phenotype of a mutation responsible for disease.

Original languageEnglish
Pages (from-to)623-636
Number of pages14
JournalJournal of Molecular and Cellular Cardiology
Volume35
Issue number6
DOIs
Publication statusPublished - 01-06-2003

Fingerprint

Familial Hypertrophic Cardiomyopathy
Mutation
Hypertrophic Cardiomyopathy
Exons
Introns
Penetrance
Genes
Sudden Cardiac Death
Phenotype
Myosin Subfragments
Chromosomes, Human, Pair 14
Reading Frames
Chromosomes, Human, Pair 11
Myosin Heavy Chains
Russia
Genetic Polymorphisms
Codon
India
Glutamic Acid

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Waldmüller, Stephan ; Sakthivel, Sadayappan ; Saadi, Abdul Vahab ; Selignow, Carmen ; Rakesh, Pareppally Gopal ; Golubenko, Maria ; Joseph, Pulavelli Kurian ; Padmakumar, Ramachandran ; Richard, Pascale ; Schwartz, Ketty ; Tharakan, Jagan Mohan ; Rajamanickam, Chellam ; Vosberg, Hans Peter. / Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy. In: Journal of Molecular and Cellular Cardiology. 2003 ; Vol. 35, No. 6. pp. 623-636.
@article{b5499e7e83b949a38ca4cb3a61613629,
title = "Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy",
abstract = "Mutations causing familial hypertrophic cardiomyopathy (HCM) have been described in at least 11 genes encoding cardiac sarcomeric proteins. In this study, three previously unknown deletions have been identified in the human cardiac genes coding for β-myosin heavy chain (MYH7 on chromosome 14) and myosin-binding protein-C (MYBPC3 on chromosome 11). In family MM, a 3-bp deletion in MYH7 was detected to be associated with loss of glutamic acid in position 927 (ΔE927) of the myosin rod. In two other families (HH and NP, related by a common founder) a 2-bp loss in codon 453 (exon 16) of MYBPC3 was identified as the presumable cause of a translation reading frame shift. Taken together 15 living mutation carriers were investigated. Six deceased family members (with five cases of premature sudden cardiac death (SCD) in families MM and NP) were either obligate or suspected mutation carriers. In addition to these mutations a 25-bp deletion in intron 32 of MYBPC3 was identified in family MM (five carriers) and in a fourth family (MiR, one HCM patient, three deletion carriers). In agreement with the loss of the regular splicing branch point in the altered intron 32, a splicing deficiency was observed in an exon trapping experiment using MYBPC3 exon 33 as a test substrate. Varying disease profiles assessed using standard clinical, ECG and echocardiographic procedures in conjunction with mutation analysis led to the following conclusions: (1) In family MM the ΔE927 deletion in MYH7 was assumed to be associated with complete penetrance. Two cases of reported SCD might have been related to this mutation. (2) The two families, HH and NP, distantly related by a common founder, and both suffering from a 2-bp deletion in exon 16 of MYBPC3 differed in their average phenotypes. In family NP, four cases of cardiac death were documented, whereas no cardiac-related death was reported from family HH. These results support the notion that mutations in HCM genes may directly determine disease penetrance and severity; however, a contribution of additional, unidentified factors (genes) to the HCM phenotype can - at least in some cases - not be excluded. (3) The deletion in intron 32 of MYBPC3 was seen in two families, but in both its relation to disease was not unequivocal. In addition, this deletion was observed in 16 of 229 unrelated healthy individuals of the population of the South Indian states of Kerala and Tamil Nadu. It was not seen in 270 Caucasians from Russia and western Europe. Hence, it is considered to represent a regional genetic polymorphism restricted to southern India. The association of the deletion with altered splicing in transfected cells suggests that this deletion may create a {"}modifying gene{"}, which is per se not or only rarely causing HCM, but which may enhance the phenotype of a mutation responsible for disease.",
author = "Stephan Waldm{\"u}ller and Sadayappan Sakthivel and Saadi, {Abdul Vahab} and Carmen Selignow and Rakesh, {Pareppally Gopal} and Maria Golubenko and Joseph, {Pulavelli Kurian} and Ramachandran Padmakumar and Pascale Richard and Ketty Schwartz and Tharakan, {Jagan Mohan} and Chellam Rajamanickam and Vosberg, {Hans Peter}",
year = "2003",
month = "6",
day = "1",
doi = "10.1016/S0022-2828(03)00050-6",
language = "English",
volume = "35",
pages = "623--636",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "6",

}

Waldmüller, S, Sakthivel, S, Saadi, AV, Selignow, C, Rakesh, PG, Golubenko, M, Joseph, PK, Padmakumar, R, Richard, P, Schwartz, K, Tharakan, JM, Rajamanickam, C & Vosberg, HP 2003, 'Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy', Journal of Molecular and Cellular Cardiology, vol. 35, no. 6, pp. 623-636. https://doi.org/10.1016/S0022-2828(03)00050-6

Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy. / Waldmüller, Stephan; Sakthivel, Sadayappan; Saadi, Abdul Vahab; Selignow, Carmen; Rakesh, Pareppally Gopal; Golubenko, Maria; Joseph, Pulavelli Kurian; Padmakumar, Ramachandran; Richard, Pascale; Schwartz, Ketty; Tharakan, Jagan Mohan; Rajamanickam, Chellam; Vosberg, Hans Peter.

In: Journal of Molecular and Cellular Cardiology, Vol. 35, No. 6, 01.06.2003, p. 623-636.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy

AU - Waldmüller, Stephan

AU - Sakthivel, Sadayappan

AU - Saadi, Abdul Vahab

AU - Selignow, Carmen

AU - Rakesh, Pareppally Gopal

AU - Golubenko, Maria

AU - Joseph, Pulavelli Kurian

AU - Padmakumar, Ramachandran

AU - Richard, Pascale

AU - Schwartz, Ketty

AU - Tharakan, Jagan Mohan

AU - Rajamanickam, Chellam

AU - Vosberg, Hans Peter

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Mutations causing familial hypertrophic cardiomyopathy (HCM) have been described in at least 11 genes encoding cardiac sarcomeric proteins. In this study, three previously unknown deletions have been identified in the human cardiac genes coding for β-myosin heavy chain (MYH7 on chromosome 14) and myosin-binding protein-C (MYBPC3 on chromosome 11). In family MM, a 3-bp deletion in MYH7 was detected to be associated with loss of glutamic acid in position 927 (ΔE927) of the myosin rod. In two other families (HH and NP, related by a common founder) a 2-bp loss in codon 453 (exon 16) of MYBPC3 was identified as the presumable cause of a translation reading frame shift. Taken together 15 living mutation carriers were investigated. Six deceased family members (with five cases of premature sudden cardiac death (SCD) in families MM and NP) were either obligate or suspected mutation carriers. In addition to these mutations a 25-bp deletion in intron 32 of MYBPC3 was identified in family MM (five carriers) and in a fourth family (MiR, one HCM patient, three deletion carriers). In agreement with the loss of the regular splicing branch point in the altered intron 32, a splicing deficiency was observed in an exon trapping experiment using MYBPC3 exon 33 as a test substrate. Varying disease profiles assessed using standard clinical, ECG and echocardiographic procedures in conjunction with mutation analysis led to the following conclusions: (1) In family MM the ΔE927 deletion in MYH7 was assumed to be associated with complete penetrance. Two cases of reported SCD might have been related to this mutation. (2) The two families, HH and NP, distantly related by a common founder, and both suffering from a 2-bp deletion in exon 16 of MYBPC3 differed in their average phenotypes. In family NP, four cases of cardiac death were documented, whereas no cardiac-related death was reported from family HH. These results support the notion that mutations in HCM genes may directly determine disease penetrance and severity; however, a contribution of additional, unidentified factors (genes) to the HCM phenotype can - at least in some cases - not be excluded. (3) The deletion in intron 32 of MYBPC3 was seen in two families, but in both its relation to disease was not unequivocal. In addition, this deletion was observed in 16 of 229 unrelated healthy individuals of the population of the South Indian states of Kerala and Tamil Nadu. It was not seen in 270 Caucasians from Russia and western Europe. Hence, it is considered to represent a regional genetic polymorphism restricted to southern India. The association of the deletion with altered splicing in transfected cells suggests that this deletion may create a "modifying gene", which is per se not or only rarely causing HCM, but which may enhance the phenotype of a mutation responsible for disease.

AB - Mutations causing familial hypertrophic cardiomyopathy (HCM) have been described in at least 11 genes encoding cardiac sarcomeric proteins. In this study, three previously unknown deletions have been identified in the human cardiac genes coding for β-myosin heavy chain (MYH7 on chromosome 14) and myosin-binding protein-C (MYBPC3 on chromosome 11). In family MM, a 3-bp deletion in MYH7 was detected to be associated with loss of glutamic acid in position 927 (ΔE927) of the myosin rod. In two other families (HH and NP, related by a common founder) a 2-bp loss in codon 453 (exon 16) of MYBPC3 was identified as the presumable cause of a translation reading frame shift. Taken together 15 living mutation carriers were investigated. Six deceased family members (with five cases of premature sudden cardiac death (SCD) in families MM and NP) were either obligate or suspected mutation carriers. In addition to these mutations a 25-bp deletion in intron 32 of MYBPC3 was identified in family MM (five carriers) and in a fourth family (MiR, one HCM patient, three deletion carriers). In agreement with the loss of the regular splicing branch point in the altered intron 32, a splicing deficiency was observed in an exon trapping experiment using MYBPC3 exon 33 as a test substrate. Varying disease profiles assessed using standard clinical, ECG and echocardiographic procedures in conjunction with mutation analysis led to the following conclusions: (1) In family MM the ΔE927 deletion in MYH7 was assumed to be associated with complete penetrance. Two cases of reported SCD might have been related to this mutation. (2) The two families, HH and NP, distantly related by a common founder, and both suffering from a 2-bp deletion in exon 16 of MYBPC3 differed in their average phenotypes. In family NP, four cases of cardiac death were documented, whereas no cardiac-related death was reported from family HH. These results support the notion that mutations in HCM genes may directly determine disease penetrance and severity; however, a contribution of additional, unidentified factors (genes) to the HCM phenotype can - at least in some cases - not be excluded. (3) The deletion in intron 32 of MYBPC3 was seen in two families, but in both its relation to disease was not unequivocal. In addition, this deletion was observed in 16 of 229 unrelated healthy individuals of the population of the South Indian states of Kerala and Tamil Nadu. It was not seen in 270 Caucasians from Russia and western Europe. Hence, it is considered to represent a regional genetic polymorphism restricted to southern India. The association of the deletion with altered splicing in transfected cells suggests that this deletion may create a "modifying gene", which is per se not or only rarely causing HCM, but which may enhance the phenotype of a mutation responsible for disease.

UR - http://www.scopus.com/inward/record.url?scp=12444285444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444285444&partnerID=8YFLogxK

U2 - 10.1016/S0022-2828(03)00050-6

DO - 10.1016/S0022-2828(03)00050-6

M3 - Article

C2 - 12788380

AN - SCOPUS:12444285444

VL - 35

SP - 623

EP - 636

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 6

ER -